The table below shows ABEONA THERAPEUTICS INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$5.82M
-
$3.50M
$1.41M
$3.00M
$10.00M
Cost of revenue
$1.53M
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$26.81M
$34.36M
$31.09M
$28.96M
$38.73M
$30.14M
SG&A
$65.03M
ABEO annual revenue (10-K history)
ABEONA THERAPEUTICS INC. reported annual revenue of $5.82M for fiscal year 2025. That is up 66.3% from $3.50M in fiscal 2023. Over the 10 fiscal years shown, annual revenue grew from $925.00K (FY 2014) to $5.82M. Figures come from the company's audited annual reports as filed with the SEC.